Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis
- 1 May 1998
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 53 (5), 1399-1404
- https://doi.org/10.1046/j.1523-1755.1998.00875.x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicityAmerican Journal of Kidney Diseases, 1995
- Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid functionKidney International, 1993
- The spectrum of bone disease in end-stage renal failure—An evolving disorderKidney International, 1993
- Phosphate Dialytic Removal: Enhancement of Phosphate Cellular Clearance by Biofiltration (with Acetate-Free Buffer Dialysate)Nephron, 1992
- Control of Hyperphosphatemia in Chronic Renal FailureSeminars in Dialysis, 1990
- The absorption of dietary phosphorus and calcium in hemodialysis patientsKidney International, 1986
- Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing DialysisThe New England Journal of Medicine, 1986
- Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysisKidney International, 1982
- METABOLIC STUDIES OF LOW PROTEIN DIETS IN UREMIAMedicine, 1973
- HYPERALUMINqMIA FROM ALUMINIUM RESINS IN RENAL FAILUREThe Lancet, 1970